结肠上皮来源硒蛋白P是结肠炎相关癌症抗氧化保护的关键来源
该研究利用条件性敲除小鼠在氧化偶氮甲烷/葡聚糖硫酸钠结肠炎相关癌症模型中,分别删除肝脏、髓系或肠上皮的硒蛋白P(SELENOP),发现仅上皮特异性缺失增加肿瘤发生,且SELENOP在溃疡性结肠炎(UC)结肠活检中下调并与内镜严重程度和S100A8表达负相关,提示结肠上皮SELENOP是局部抗氧化保护的主要贡献者。
要点
- 肝脏或髓系SELENOP缺失不影响CAC肿瘤发生,上皮缺失则增加肿瘤。
- UC结肠活检中SELENOP下调,与内镜严重程度及S100A8表达负相关。
- 结肠SELENOP或可评估IBD硒水平并预测UC严重程度及CAC风险。
核心结论
- 外周SELENOP池对CAC非必需,结肠上皮SELENOP是局部抗氧化能力的主要贡献者。
- 结肠SELENOP是评估IBD患者硒水平与活性的最 informative 指标,可能作为UC疾病严重程度及CAC易感性的新型生物标志物。
研究设计与样本
- 研究采用Selenop floxed小鼠与Cre驱动系杂交,分别从肝脏、髓系或肠上皮删除Selenop,并置于AOM/DSS实验性CAC方案。
- 同时评估人UC类器官中SELENOP缺失,并在人及成人UC样本中查询表达。
主要发现
- 肝脏特异性或髓系特异性Selenop缺失未能改变AOM/DSS介导的肿瘤发生。
- 上皮特异性缺失增加CAC肿瘤发生,可能源于氧化应激升高导致基因组不稳定性增加和肿瘤起始增强。
- SELENOP在UC结肠活检中下调,水平与内镜疾病严重程度和组织S100A8(钙卫蛋白)基因表达呈负相关。
临床怎么用
- 尽管全身硒状态通常通过测量肝源性血浆SELENOP水平评估,但本研究提示外周SELENOP池对CAC非必需。
- 结肠SELENOP有望作为评估IBD患者硒水平与活性的新方法,并辅助识别UC严重程度及CAC高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with inflammatory bowel disease (IBD) demonstrate nutritional selenium deficiencies and are at greater risk of developing colon cancer. Previously, we determined that global reduction of the secreted antioxidant selenium-containing protein, selenoprotein P (SELENOP), substantially increased tumor development in an experimental colitis-associated cancer (CAC) model. We next sought to delineate tissue-specific contributions of SELENOP to intestinal inflammatory carcinogenesis and define clinical context. METHODS: Selenop floxed mice crossed with Cre driver lines to delete Selenop from the liver, myeloid lineages, or intestinal epithelium were placed on an azoxymethane/dextran sodium sulfate experimental CAC protocol. SELENOP loss was assessed in human ulcerative colitis (UC) organoids, and expression was queried in human and adult UC samples. RESULTS: Although large sources of SELENOP, both liver- and myeloid-specific Selenop deletion failed to modify azoxymethane/dextran sodium sulfate-mediated tumorigenesis. Instead, epithelial-specific deletion increased CAC tumorigenesis, likely due to elevated oxidative stress with a resulting increase in genomic instability and augmented tumor initiation. SELENOP was down-regulated in UC colon biopsies and levels were inversely correlated with endoscopic disease severity and tissue S100A8 (calprotectin) gene expression. CONCLUSIONS: Although global selenium status is typically assessed by measuring liver-derived plasma SELENOP levels, our results indicate that the peripheral SELENOP pool is dispensable for CAC. Colonic epithelial SELENOP is the main contributor to local antioxidant capabilities. Thus, colonic SELENOP is the most informative means to assess selenium levels and activity in IBD patients and may serve as a novel biomarker for UC disease severity and identify patients most predisposed to CAC development.
引用
- Short SP, Pilat JM, Barrett CW, et al. Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer. Gastroenterology. 2021. PMID: 33388316. doi:10.1053/j.gastro.2020.12.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。